» Articles » PMID: 39118330

Estimation and Inference on the Partial Volume Under the Receiver Operating Characteristic Surface

Overview
Publisher Sage Publications
Specialties Public Health
Science
Date 2024 Aug 9
PMID 39118330
Authors
Affiliations
Soon will be listed here.
Abstract

measures of biomarker accuracy that employ the receiver operating characteristic surface have been proposed for biomarkers that classify patients into one of three groups: healthy, benign, or aggressive disease. The volume under the receiver operating characteristic surface summarizes the overall discriminatory ability of a biomarker in such configurations, but includes cutoffs associated with clinically irrelevant true classification rates. Due to the lethal nature of pancreatic cancer, cutoffs associated with a low true classification rate for identifying patients with pancreatic cancer may be undesirable and not appropriate for use in a clinical setting. In this project, we study the properties of a more focused criterion, the partial volume under the receiver operating characteristic surface, that summarizes the diagnostic accuracy of a marker in the three-class setting for regions restricted to only those of clinical interest. We propose methods for estimation and inference on the partial volume under the receiver operating characteristic surface under parametric and non-parametric frameworks and apply these methods to the evaluation of potential biomarkers for the diagnosis of pancreatic cancer.

References
1.
Capello M, Bantis L, Scelo G, Zhao Y, Li P, Dhillon D . Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017; 109(4). PMC: 5441297. DOI: 10.1093/jnci/djw266. View

2.
Xiong C, van Belle G, Miller J, Morris J . Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groups. Stat Med. 2005; 25(7):1251-73. DOI: 10.1002/sim.2433. View

3.
Dodd L, Pepe M . Partial AUC estimation and regression. Biometrics. 2003; 59(3):614-23. DOI: 10.1111/1541-0420.00071. View

4.
Deshwar A, Sugar E, Torto D, De Jesus-Acosta A, Weiss M, Wolfgang C . Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis. Ann Pancreat Cancer. 2018; 1. PMC: 5909699. DOI: 10.21037/apc.2018.02.01. View

5.
Dreiseitl S, Ohno-Machado L, Binder M . Comparing three-class diagnostic tests by three-way ROC analysis. Med Decis Making. 2000; 20(3):323-31. DOI: 10.1177/0272989X0002000309. View